Stock MCRB SERES THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Seres Therapeutics, Inc.

Equities

MCRB

US81750R1023

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.9199 USD -0.49% Intraday chart for Seres Therapeutics, Inc. -9.81% -34.29%
May. 09 Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating MT
May. 09 Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SERES THERAPEUTICS, INC. Stock Seres Therapeutics, Inc.
 140M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
BIONTECH SE Stock BioNTech SE
 22.41B -
ARGENX SE Stock argenx SE
 22.28B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. MCRB Stock
  4. Charts Seres Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW